Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series.

Da, J; Ali, K; Lu, K; Lou, H; Qiu, Y; Shan, J; Wu, L

Da, J; Ali, K; Lu, K; Lou, H; Qiu, Y; Shan, J; Wu, L.

Affiliation

Da J; Department of, Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ali K; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Lu K; Department of, Oncological Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lou H; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Qiu Y; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Shan J; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Wu L; Department of, Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Clin Exp Dermatol ; 47(2): 423-425, 2022 02.

Article in En | MEDLINE | ID: mdl-34482550

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Dermatitis, Atopic/drug therapy; Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors; Off-Label Use; Child, Preschool; Drug Therapy, Combination; Female; Histamine Antagonists/therapeutic use; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic / Interleukin-4 Receptor alpha Subunit / Off-Label Use / Antibodies, Monoclonal, Humanized Limits: Child, preschool / Female / Humans / Male Language: En Journal: Clin Exp Dermatol Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google